# Advisor Review - Advisor 1/3

**Role:** Academic advisor checking for fatal errors
**Model:** gpt-5.2-2025-12-11
**Paper:** paper.pdf
**Reasoning effort:** high
**Timestamp:** 2026-01-26T03:36:32.507292
**Response ID:** resp_02a1183dcf3d44df006976d27a0bb881938eefe5e97dd9200c
**Tokens:** 7792 in / 8506 out
**Response SHA256:** eeeac5865409ed80

---

I checked the draft strictly for **fatal** issues in the four categories you specified (data–design alignment, regression sanity, completeness, internal consistency). I did **not** evaluate writing, contribution, or minor methodological preferences.

## 1) DATA–DESIGN ALIGNMENT (CRITICAL)
- **Treatment timing vs. data coverage:** Treatment cohorts run through **2023** (latest treated year listed: KY/MA/ME/NE/OH in 2023). Outcome data are **2014–2023**. So **max(treatment year) ≤ max(data year)** holds. No “treated in 2024” units are analyzed as treated.
- **Post-treatment observations:**  
  - Early cohorts (2018, 2019, 2020, 2021, 2022) clearly have post-treatment years in-sample.  
  - The **2023 cohort** only has (at most) event time 0 in 2023 (no 2024+), but this is still a defined post period for an “immediate effect” and is not a design impossibility.
- **Treatment definition consistency:** “Year of first legal bet / first statewide availability” is used consistently in the data section and in Appendix Table 4 (cohort table). The narrative discussion of 2024 is clearly outside the estimation window and is handled by coding those states as not-yet/never treated through 2023 or dropping them.

No fatal misalignment found.

## 2) REGRESSION SANITY (CRITICAL)
I scanned Tables 1–3 and the event-study Table 2 for mechanical red flags (impossible values, nonsensical magnitudes given the outcome is **jobs in levels**, SE pathologies, missing/NaN/Inf).
- **Table 1:** ATT and SE magnitudes are plausible for employment levels; p-values align with coefficient/SE ratios; CIs are arithmetically consistent with SEs.
- **Table 2 (event study):** Coefficients fluctuate around zero; SEs grow at longer horizons (expected with fewer observations). No negative/NA/Inf SEs; CIs match the reported SEs.
- **Table 3:** Duplicates the main estimator comparison; values are internally consistent.

No fatal regression-output sanity violations found.

## 3) COMPLETENESS (CRITICAL)
- No placeholders (“TBD/TODO/XXX/NA/NaN/Inf”) appear in the reported tables.
- Regression tables report **standard errors** and **N** (Tables 1–3; Table 2 includes N in the note).
- The paper does not cite missing/nonexistent figures or tables by number (it discusses “visual evidence” but does not claim “Figure X” exists and then omit it).

No fatal completeness problems found.

## 4) INTERNAL CONSISTENCY (CRITICAL)
- Abstract numbers match Table 1 (ATT, SE, p-value, CI; TWFE comparison).
- The event-study pretrend joint-test p-value stated in text matches the note in Table 2.
- Sample period and cohort timing are consistent throughout (2014–2023 outcome window; cohorts through 2023; 2024 discussed only as background/out of sample).

No fatal internal inconsistencies found.

ADVISOR VERDICT: PASS